TG Therapeutics
TGTX
TGTX
146 hedge funds and large institutions have $639M invested in TG Therapeutics in 2020 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 46 increasing their positions, 45 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.83% more ownership
Funds ownership: 58.45% → 59.28% (+0.83%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1% less capital invested
Capital invested by funds: $646M → $639M (-$6.74M)
Holders
146
Holding in Top 10
2
Calls
$40.5M
Puts
$8.37M
Top Buyers
| 1 | +$76.5M | |
| 2 | +$16.6M | |
| 3 | +$12.2M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$11.8M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$9.31M |
Top Sellers
| 1 | -$28.3M | |
| 2 | -$19.8M | |
| 3 | -$10.4M | |
| 4 |
Renaissance Technologies
New York
|
-$6.57M |
| 5 |
D.E. Shaw & Co
New York
|
-$5.95M |